NuVision Biotherapies
PrivateLast Round
Early Funding
Feb 5, 2026
Total Funding Raised
$7.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NuVision Biotherapies is a biotechnology company that develops and manufactures ophthalmic therapy products designed to offer surgeons new therapies for ocular care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2G
Customer Profile
Hardware Sales, Government Contracts, Freemium
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuVision Biotherapies Comparables
Compare NuVision Biotherapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioTissue | 84% | |
| Merakris Therapeutics | 78% | |
| Corza Medical | 76% |
NuVision Biotherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 5, 2026 | ||||
| VC Round | Mar 8, 2023 | ||||
| VC Round | Jul 15, 2021 | ||||
| Seed | Feb 8, 2018 | ||||
| Seed | Jul 28, 2015 |
NuVision Biotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Group | VC Round, Early Funding |
| British Business Bank | VC Round, Early Funding |
| Mercia Ventures | Early Funding |
| Mercia Asset Management | VC Round |
| Mercia Ventures | VC Round |
| The University of Nottingham | Seed, VC Round, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
Raised $6.5M in early funding.
- Jan 31, 2025
Launched a new clinical product despite manufacturing challenges.
NuVision Biotherapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access